PRR5 and Parkinson disease: BACH1 has been proposed as a therapeutic target for several neurological diseases (e.g., Parkinson’s disease, multiple sclerosis), and PRR5 is part of the mTORC2 protein complex that is decreased in the AD brain at the protein level [1, 29, 36, 54].